Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Non-Current Debt (2021 - 2026)

Core Scientific has reported Non-Current Debt over the past 6 years, most recently at $1.1 billion for Q1 2026.

  • Quarterly results put Non-Current Debt at $1.1 billion for Q1 2026, down 0.95% from a year ago — trailing twelve months through Mar 2026 was $1.1 billion (down 0.95% YoY), and the annual figure for FY2025 was $1.1 billion, down 1.27%.
  • Non-Current Debt reached $1.1 billion in Q1 2026 per CORZ's latest filing, roughly flat from $1.1 billion in the prior quarter.
  • Across five years, Non-Current Debt topped out at $1.1 billion in Q4 2024 and bottomed at $45000.0 in Q2 2023.
  • Median Non-Current Debt over the past 5 years was $952.4 million (2022), compared with a mean of $800.8 million.
  • The largest annual shift saw Non-Current Debt plummeted 99.99% in 2023 before it skyrocketed 1170468.89% in 2024.
  • Over 5 years, Non-Current Debt stood at $852.3 million in 2022, then fell by 19.74% to $684.1 million in 2023, then surged by 57.0% to $1.1 billion in 2024, then fell by 1.27% to $1.1 billion in 2025, then grew by 0.13% to $1.1 billion in 2026.
  • Business Quant data shows Non-Current Debt for CORZ at $1.1 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.1 billion in Q3 2025.